Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The dangers of stopping a trial too early.

Briel M, Bassler D, Wang AT, Guyatt GH, Montori VM.

J Bone Joint Surg Am. 2012 Jul 18;94 Suppl 1:56-60. doi: 10.2106/JBJS.K.01412.

PMID:
22810449
2.

Randomized trials stopped early for benefit: a systematic review.

Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH.

JAMA. 2005 Nov 2;294(17):2203-9. Review.

PMID:
16264162
3.

Early stopping rules in oncology: considerations for clinicians.

Mukherjee SD, Goffin JR, Taylor V, Anderson KK, Pond GR.

Eur J Cancer. 2011 Nov;47(16):2381-6. doi: 10.1016/j.ejca.2011.05.019. Epub 2011 Jun 16. Review.

PMID:
21684153
4.

Randomized trials stopped early for harm in HIV/AIDS: a systematic survey.

Mills E, Cooper C, Wu P, Rachlis B, Singh S, Guyatt GH.

HIV Clin Trials. 2006 Jan-Feb;7(1):24-33. Review.

PMID:
16684642
5.

Early stopping of randomized clinical trials for overt efficacy is problematic.

Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G.

J Clin Epidemiol. 2008 Mar;61(3):241-6. doi: 10.1016/j.jclinepi.2007.07.016. Review.

PMID:
18226746
6.

Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerations.

Ball G, Piller LB, Silverman MH.

Contemp Clin Trials. 2011 Sep;32 Suppl 1:S2-4. doi: 10.1016/j.cct.2011.05.010. Epub 2011 Jun 6.

PMID:
21664987
7.

Data monitoring committees, interim analysis and early termination in paediatric trials.

Fernandes RM, van der Lee JH, Offringa M.

Acta Paediatr. 2011 Oct;100(10):1386-92. doi: 10.1111/j.1651-2227.2011.02282.x. Epub 2011 Apr 8.

PMID:
21434998
8.

Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).

Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Culebro CR, da Silva SA, Flynn DN, Elamin MB, Strahm B, Murad MH, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Abu Elnour NO, You JJ, Karanicolas PJ, Bucher HC, Lampropulos JF, Nordmann AJ, Burns KE, Mulla SM, Raatz H, Sood A, Kaur J, Bankhead CR, Mullan RJ, Nerenberg KA, Vandvik PO, Coto-Yglesias F, Schünemann H, Tuche F, Chrispim PP, Cook DJ, Lutz K, Ribic CM, Vale N, Erwin PJ, Perera R, Zhou Q, Heels-Ansdell D, Ramsay T, Walter SD, Guyatt GH.

Trials. 2009 Jul 6;10:49. doi: 10.1186/1745-6215-10-49.

9.

An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.

Stegert M, Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Briel M; DISCO study group..

J Clin Epidemiol. 2016 Jan;69:152-60. doi: 10.1016/j.jclinepi.2015.05.023. Epub 2015 Jun 4. Review.

PMID:
26361993
10.

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.

Prutsky GJ, Domecq JP, Erwin PJ, Briel M, Montori VM, Akl EA, Meerpohl JJ, Bassler D, Schandelmaier S, Walter SD, Zhou Q, Coello PA, Moja L, Walter M, Thorlund K, Glasziou P, Kunz R, Ferreira-Gonzalez I, Busse J, Sun X, Kristiansen A, Kasenda B, Qasim-Agha O, Pagano G, Pardo-Hernandez H, Urrutia G, Murad MH, Guyatt G.

Trials. 2013 Oct 16;14:335. doi: 10.1186/1745-6215-14-335. Review.

11.

Stopping a trial early - and then what?

Wittes J.

Clin Trials. 2012 Dec;9(6):714-20. doi: 10.1177/1740774512454600. Epub 2012 Aug 9.

PMID:
22879573
12.

Issues in data monitoring and interim analysis of trials.

Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, Elbourne DR, McLeer SK, Parmar MK, Pocock SJ, Spiegelhalter DJ, Sydes MR, Walker AE, Wallace SA; DAMOCLES study group..

Health Technol Assess. 2005 Mar;9(7):1-238, iii-iv. Review.

13.

Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.

Korn EL, Freidlin B, Mooney M.

J Clin Oncol. 2009 Apr 1;27(10):1712-21. doi: 10.1200/JCO.2008.19.5339. Epub 2009 Feb 23.

14.

Stopping guidelines for an effectiveness trial: what should the protocol specify?

Tyson JE, Pedroza C, Wallace D, D'Angio C, Bell EF, Das A.

Trials. 2016 May 10;17(1):240. doi: 10.1186/s13063-016-1367-4.

15.

Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.

Korn EL, Freidlin B.

Am J Bioeth. 2011 Mar;11(3):2-10. doi: 10.1080/15265161.2010.546471.

PMID:
21400374
16.

Ethical issues in stopping randomized trials early because of apparent benefit.

Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH.

Ann Intern Med. 2007 Jun 19;146(12):878-81.

PMID:
17577007
18.

Adaptive Bayesian randomized trials: realizing their potential.

Pullenayegum EM.

J Bone Joint Surg Am. 2012 Jul 18;94 Suppl 1:29-33. doi: 10.2106/JBJS.L.00094.

PMID:
22810444
19.

Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.

Murad MH, Guyatt GH, Domecq JP, Vernooij RW, Erwin PJ, Meerpohl JJ, Prutsky GJ, Akl EA, Mueller K, Bassler D, Schandelmaier S, Walter SD, Busse JW, Kasenda B, Pagano G, Pardo-Hernandez H, Montori VM, Wang Z, Briel M.

J Clin Epidemiol. 2017 Feb;82:12-19. doi: 10.1016/j.jclinepi.2016.10.006. Epub 2016 Nov 8. Review.

PMID:
27832953
20.

Stopping clinical trials early for benefit: impact on estimation.

Freidlin B, Korn EL.

Clin Trials. 2009 Apr;6(2):119-25. doi: 10.1177/1740774509102310.

PMID:
19342463

Supplemental Content

Support Center